Shining on Major News: Barrick Gold Corporation (NYSE:ABX), Akebia Therapeutics, Inc. (NASDAQ:AKBA), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Kraton Performance Polymers (NYSE:KRA), Con-way (NYSE:CNW)

On 23 July, Barrick Gold Corporation (NYSE:ABX) announced it has completed the divestiture of its Cowal mine in New South Wales, Australia to Evolution Mining for a total cash consideration of $550 million. Proceeds from the sale of Cowal will be used to repay debt. Barrick Gold Corporation (NYSE:ABX) belongs to Basic Materials sector. Its net profit margin is -29.80% and weekly performance is -9.54%. On last trading day company shares ended up $6.54. Barrick Gold Corporation (NYSE:ABX) distance from 50-day simple moving average (SMA50) is -34.99%.

Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares decreased -1.32% in last trading session and ended the day at $10.48. AKBA return on assets is -33.00%. Akebia Therapeutics, Inc. (NASDAQ:AKBA) quarterly performance is 38.99%.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced the dosing of the first patient in a Phase 2 study of investigational recombinant human beta-glucuronidase (rhGUS, UX003) in patients under five years old with mucopolysaccharidosis 7 (MPS 7, Sly syndrome), potentially including patients with non-immune hydrops fetalis, a severe infantile presentation of the disease. On 05 August, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) shares moved up 3.28% and was closed at $120.27. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) year to date (YTD) performance is 174.09%.

ON 29 July, Kraton Performance Polymers Inc. (NYSE:KRA) swung to a net loss for the quarter ended Jun. 30, 2015. The company has made a net loss of $5.56 million, or $ 0.18 a share in the quarter, against a net profit of $11.14 million, or $0.33 a share in the last year period. Kraton Performance Polymers Inc. (NYSE:KRA) ended the last trading day at $21.03. Company weekly volatility is calculated as 4.08% and price to cash ratio as 10.95. Kraton Performance Polymers Inc. (NYSE:KRA) showed a weekly performance of -3.09%.

On 29 July, Con-way Inc. (NYSE:CNW) announced second-quarter 2015 net income of $44.0 million, or 76 cents per diluted share. In the second quarter of 2014, Con-way reported net income of $53.7 million, or 93 cents per diluted share.Con-way Inc. (NYSE:CNW) shares decreased -0.28% in last trading session and ended the day at $38.51. CNW Gross Margin is 65.70% and its return on assets is 4.10%. Con-way Inc. (NYSE:CNW) quarterly performance is -6.56%.

Leave a Reply

Your email address will not be published. Required fields are marked *